Corpus Intelligence IC Memo — FAIRVIEW LAKES REGIONAL MEDICAL CTR 2026-04-26 05:28 UTC
IC Memo — FAIRVIEW LAKES REGIONAL MEDICAL CTR
Investment Committee Memorandum | MN | 55 beds | Grade B | EBITDA uplift $8.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FAIRVIEW LAKES REGIONAL MEDICAL CTR

CCN 240050 | CHISAGO, MN | 55 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

FAIRVIEW LAKES REGIONAL MEDICAL CTR is a 55-bed suburban community hospital in CHISAGO, MN with $119.6M in net patient revenue and a 10.3% operating margin. The hospital serves a payer mix of 22.7% Medicare, 5.1% Medicaid, and 72.2% commercial.

Thesis: Turnaround. Our ML models identify $8.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 10.3% to 17.6% (+736bps).

Net Revenue HCRIS$119.6M
Current EBITDA COMPUTED$12.3M
Operating Margin COMPUTED10.3%
Occupancy HCRIS56.9%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS35.6%
Distress Probability ML45.6%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
28
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of 10.3% places it above the state median. Among 28 size-comparable peers (28-110 beds), the median margin is -6.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (28-110), prioritizing same-state peers. 28 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FAIRVIEW LAKES REGIONAL MEDICA (Target)MN55$119.6M10.3%
LAKEVIEW MEMORIALMN68$411.9M60.9%
SANFORD BEMIDJIMN94$312.6M-19.6%
RIDGEVIEW MEDICAL CENTERMN109$287.8M-14.2%
MAYO CLNIC HLTH SYS-ALBRT LEA MN79$271.9M-16.6%
GILLETTE CHILDRENS SPECIALTY HMN60$266.7M-6.3%
OLMSTED MEDICAL CENTERMN61$217.6M-13.6%
HEALTHEAST WOODWINDS HOSPITALMN86$210.3M-5.5%
ST. FRANCIS REGIONAL MEDICAL CMN89$192.5M-0.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.5M+210bp18mo
Cost to Collect4.5%2.5%$2.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$77K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.5M
Cost to Collect
$2.4M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.5M
Clean Claim Rate
$77K
Total EBITDA Uplift$8.8M
Current EBITDA$12.3M
+ RCM Uplift+$8.8M
Pro Forma EBITDA$21.1M
Current Margin10.3%
Pro Forma Margin17.6%
WC Released (1x)$4.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$18.9M$169.2M8.94x55.0%
Base (11x exit)10.0x11.0x$18.9M$192.3M10.16x59.0%
Bull Case9.0x11.0x$17.0M$227.5M13.35x67.9%
Bull (12x exit)9.0x12.0x$17.0M$253.2M14.86x71.6%
Bear Case11.0x10.0x$20.8M$119.0M5.72x41.7%
Bear (11x exit)11.0x11.0x$20.8M$137.7M6.61x45.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 28 hospitals with 28-110 beds
  • Same-state prioritization (n=29)
  • Comp margins: P25=-12.2% / P50=-6.3% / P75=-0.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.